Sanders Morris Harris’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $879K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $646K | Hold |
|
|||||
|
2024
Q4 | $1.08M | Buy |
|
|||||
|
2024
Q3 | $950K | Hold |
|
|||||
|
2024
Q2 | $833K | Hold |
|
|||||
|
2024
Q1 | $871K | Hold |
|
|||||
|
2023
Q4 | $663K | Hold |
|
|||||
|
2023
Q3 | $512K | Hold |
|
|||||
|
2023
Q2 | $336K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $340K | Hold |
|
|||||
|
2022
Q3 | $353K | Hold |
|
|||||
|
2022
Q2 | $351K | Hold |
|
|||||
|
2022
Q1 | $408K | Hold |
|
|||||
|
2021
Q4 | $523K | Hold |
|
|||||
|
2021
Q3 | $368K | Hold |
|
|||||
|
2021
Q2 | $388K | Hold |
|
|||||
|
2021
Q1 | $306K | Hold |
|
|||||
|
2020
Q4 | $263K | Hold |
|
|||||
|
2020
Q3 | $311K | Buy |
|